Screening for prostate cancer. Implications for drug therapy
- PMID: 7647423
- DOI: 10.2165/00002512-199506050-00001
Screening for prostate cancer. Implications for drug therapy
Similar articles
-
Molecular therapy is advancing with drugs that target pathways relevant for several cancers. Foreword.BJU Int. 2012 Oct;110 Suppl 1:1-2. doi: 10.1111/j.1464-410X.2012.11427.x. BJU Int. 2012. PMID: 23046033 No abstract available.
-
Current status and prospects of androgen depletion therapy for prostate cancer.Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):293-302. doi: 10.1016/j.beem.2008.01.010. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 18471787 Review.
-
Diagnosis and treatment of patients with prostate cancer: the nurse's role.Nurs Stand. 2007 Jun 6-12;21(39):48-56; quiz 58. doi: 10.7748/ns2007.06.21.39.48.c4568. Nurs Stand. 2007. PMID: 17569378 Review.
-
Endocrine therapy for prostate cancer.Endocrinol Metab Clin North Am. 1991 Dec;20(4):845-72. Endocrinol Metab Clin North Am. 1991. PMID: 1778180 Review.
-
'Clandestine' prostate cancer haunts.CAP Today. 1996 Feb;10(2):1, 34-6, 38 passim. CAP Today. 1996. PMID: 10160261 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical